glp-1 receptor agonist pancreatitis risk meta-analysis Glucometabolic outcomes of agonist-based therapies in patients with type 2 diabetes: a systematic review and network glp-1 receptor agonist pancreatitis risk

US$ 25.27

★★★★★ 4.3 (10 reviews)

US$ 24.07

★★★★★ 4.2 (20 reviews)

US$ 28.77

★★★★★ 4.7 (30 reviews)

US$ 28.90

★★★★★ 4.8 (8 reviews)

US$ 27.90

★★★★★ 4.9 (23 reviews)

US$ 29.00

★★★★★ 4.2 (12 reviews)

US$ 23.12

★★★★★ 4.0 (9 reviews)

US$ 23.63

★★★★★ 4.2 (29 reviews)

US$ 20.01

★★★★★ 4.8 (20 reviews)

US$ 26.46

★★★★★ 4.5 (23 reviews)

US$ 28.95

★★★★★ 4.7 (25 reviews)

US$ 26.23

★★★★★ 4.0 (14 reviews)

US$ 25.00

★★★★★ 4.2 (24 reviews)

US$ 28.27

★★★★★ 4.7 (27 reviews)

US$ 20.71

★★★★★ 4.2 (30 reviews)

US$ 24.72

★★★★★ 4.5 (7 reviews)

US$ 26.79

★★★★★ 5.0 (13 reviews)

US$ 25.84

★★★★★ 4.0 (25 reviews)

US$ 24.82

★★★★★ 4.5 (11 reviews)

US$ 24.33

★★★★★ 4.3 (14 reviews)